✦ LIBER ✦

Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report

✍ Scribed by Wade Iams, Kathyrn Eby Beckermann, Anne T. Neff, Ingrid A. Mayer…

Book ID: 120899686
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 137 KB
Volume: 30
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-013-0568-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Syndrome of inappropriate anti-diuretic

Syndrome of inappropriate anti-diuretic hormone secretion secondary to carboplatin after docetaxel-carboplatin-trastuzumab combination for early stage HER-2 positive breast cancer

✍ Natalie TURNER; Josephine STEWART; Frances BARNETT; Shane WHITE 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

HER2-positive Breast Cancer Brain Metast

HER2-positive Breast Cancer Brain Metastases: Multiple Responses to Systemic Chemotherapy and Trastuzumab—a Case Report

✍ D. N. Church; A. Bahl; A. Jones; C. G. A. Price 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 164 KB

29 FIRST LINE CHEMOTHERAPY WITH DOCETAXE

29 FIRST LINE CHEMOTHERAPY WITH DOCETAXEL/GEMCITABINE/TRASTUZUMAB (GOIM 2611) IN PATIENT WITH ADVANCED BREAST CANCER HER-2 POS: A CASE REPORT OF EARLY AND PROLONGED RESPONSE

✍ F. Riccardi; M. Rizzo; G. Carrillo; F. De Michele; S. Daniele; R. Festa; F. Ambr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Adjuvant docetaxel and cyclophosphamide

Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study

✍ Jones, Stephen E; Collea, Rufus; Paul, Devchand; Sedlacek, Scot; Favret, Anne M; 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 210 KB

Multicenter Phase III Randomized Trial C

Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients With HER2-Gene-Amplified Metastatic Breast Cancer (BCIRG 007 Study): Two Highly Active Therapeutic Regimens

✍ Valero, V.; Forbes, J.; Pegram, M. D.; Pienkowski, T.; Eiermann, W.; von Minckwi 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 257 KB

265 ORAL BCIRG 006: Superior cardiac saf

265 ORAL BCIRG 006: Superior cardiac safety of adjuvant docetaxel (T), carboplatin (C) and trastuzumab (H) compared to doxorubicin (A) and cyclophosphamide (Cyc) followed by TH in patients with early stage breast cancer and altered HER2 gene

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB